Empower is being impacted due to Crowdstrike Outage. Empower is currently experiencing system issues.  These issues should be fixed later today.  

Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Powered by Lapero